VICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided study

Project Details

Short titleVICTOR: Venetoclax or Intensive Chemotherapy for Treatment Of Favourable Risk Acute Myeloid Leukaemia: a molecularly guided study
StatusActive
Effective start/end date1/02/20 → 31/07/25

Funding

  • Cancer Research Uk
  • Abbvie Ltd